Netherlands Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Netherlands Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: We continue to expect yet another year of pharmaceutical market value contraction in the Netherlands. Having been valued at EUR6.56bn (US$8.33bn) at consumer prices in 2012, or US$498 per capita, we expect negative pressures on volume consumption of medicines as well as on their prices to remain in play, especially as the government foots over 80% of the total healthcare bill. In combination with patent expirations, we expect such pressures to prevent the market’s value growth from returning to the positive territory until 2017 at the earliest. Although the Netherlands will continue to be supplied by research-based pharmaceutical … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103197. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/netherlands-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions